TY  - RPRT
TI  - Finding the best cell lines across pan-cancer to use in pre-clinical research as a proxy for patient tumor samples considering immune cells, multi-omics, and cancer pathways
AU  - Bose, B.
AU  - Bozdag, S.
PY  - 2022
DO  - 10.1101/2022.12.18.520831
UR  - https://www.biorxiv.org/content/10.1101/2022.12.18.520831v1
ID  - 10.1101/2022.12.18.520831
ER  -